Wolfe Research Downgrades Silk Road Medical (SILK) to Underperform
Tweet Send to a Friend
Wolfe Research analyst Mike Polark downgraded Silk Road Medical (NASDAQ: SILK) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
